A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RARS-T / ring sideroblasts and thrombocytosis

[Related PubMed/MEDLINE]
Total Number of Papers: 13
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RARS-T  (>> Co-occurring Abbreviation)
Long Form:   ring sideroblasts and thrombocytosis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T. aCML, CMML, JMML, MDS/MPN, WHO
2016 Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes. aCML, CMML, JMML
2016 Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. MDS, MPN
2014 An active isodicentric x chromosome in a case of refractory anaemia with ring sideroblasts associated with marked thrombocytosis. WHO
2014 Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable. aCML, CMML, JMML, MDS/MPN
2013 Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms. MDS/MPN, MFC
2012 Refractory anemia with ring sideroblasts associated with marked thrombocytosis: case report and literature review. JAK2
2011 Myelodysplastic/myeloproliferative neoplasms. CMML, JMML, MDS, MDS/MPN, MPN, WHO
2010 Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis. ---
10  2010 JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia. AML, MDS
11  2009 Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category? ET, MDS/MPN, WHO
12  2008 JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. ---
13  2006 Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. CMPD, MDS